رجوع
نطاق اليوم
KWD 29.00
KWD 29.50
نطاق 52 أسبوعًا
KWD 19.44
KWD 42.81
حجم التداول
1,129
متوسط 50 يوم / 200 يوم
KWD 33.36
/
KWD 35.01
الإغلاق السابق
KWD 29.00
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 536.1 | 0.2 |
| P/B | 17.0 | 3.0 |
| ROE % | 3.4 | 3.6 |
| Net Margin % | 1.8 | 3.8 |
| Rev Growth 5Y % | 72.2 | 9.9 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.00
KWD 0.00 – KWD 0.00
|
353.27M | 0 |
| FY2029 |
KWD 0.00
KWD 0.00 – KWD 0.00
|
301.63M | 0 |
| FY2028 |
KWD 1.21
KWD 1.11 – KWD 1.30
|
250.08M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-10 | N/A | KWD 0.12 | — |
| 2025-08-14 | N/A | -KWD 0.06 | — |
| 2025-03-11 | N/A | -KWD 0.10 | — |
| 2024-10-10 | N/A | -KWD 0.01 | — |
| 2024-03-13 | N/A | -KWD 0.28 | — |
| 2023-06-30 | N/A | -KWD 0.15 | — |
| 2022-12-31 | N/A | -KWD 0.34 | — |
| 2022-06-30 | N/A | -KWD 0.12 | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 72.16% annually over 5 years — strong growth
ROE of 3.37% is below average
Debt/Equity of 0.06 — conservative balance sheet
Negative free cash flow of -2.40M
P/E of 536.05 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.54%
النمو
Revenue Growth (5Y)
72.16%
Revenue (1Y)60.62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
3.37%
ROIC7.75%
Net Margin1.75%
Op. Margin6.04%
الأمان
Debt / Equity
0.06
Current Ratio1.96
Interest Coverage24.04
التقييم
P/E Ratio
536.05
Forward P/E104.73
P/B Ratio16.97
EV/EBITDA153.39
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60.62% | Revenue Growth (3Y) | 90.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 72.16% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 121.36M | Net Income (TTM) | 2.12M |
| ROE | 3.37% | ROA | 1.98% |
| Gross Margin | 86.39% | Operating Margin | 6.04% |
| Net Margin | 1.75% | Free Cash Flow (TTM) | -2.40M |
| ROIC | 7.75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 1.96 |
| Interest Coverage | 24.04 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 536.05 | Forward P/E | 104.73 |
| P/B Ratio | 16.97 | P/S Ratio | 9.36 |
| PEG Ratio | -3.55 | Forward PEG | N/A |
| EV/EBITDA | 153.39 | Fwd EV/EBITDA | N/A |
| Forward P/S | 7.14 | Fwd Earnings Yield | 0.95% |
| FCF Yield | -0.21% | ||
| Market Cap | 1.14B | Enterprise Value | 1.12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 121.36M | 75.56M | 33.56M | 17.99M | 13.82M |
| Net Income | 2.12M | -3.72M | -13.73M | -14.60M | -7.54M |
| EPS (Diluted) | 0.05 | -0.10 | -0.38 | -0.43 | -0.23 |
| Gross Profit | 104.84M | 62.03M | 28.47M | 10.77M | 10.07M |
| Operating Income | 7.33M | -5.00M | -13.19M | -13.45M | -8.77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 107.26M | 84.54M | 71.46M | 82.95M | 91.34M |
| Total Liabilities | 40.30M | 25.79M | 14.75M | 14.09M | 14.36M |
| Shareholders' Equity | 66.96M | 58.75M | 56.71M | 68.86M | 76.98M |
| Total Debt | 3.94M | 1.79M | 2.14M | 1.91M | 2.15M |
| Cash & Equivalents | 15.67M | 17.46M | 14.21M | 24.07M | 28.62M |
| Current Assets | 65.52M | 44.75M | 27.19M | 31.39M | 32.89M |
| Current Liabilities | 33.40M | 20.90M | 13.19M | 12.59M | 11.29M |